Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
It is unclear whether non-invasive screening of asymptomatic diabetic patients for coronary artery disease (CAD) may improve cardiac outcomes. Thus, we performed a systematic literature review and meta-analysis of randomised controlled trials (RCT's) on this topic. We searched appropriate RCT's in five online databases (PubMed/MEDLINE, Cochrane Library, Embase, Scopus, and Web of Science) from January 2000 to November 2017 and in 41 recent reviews. Two investigators independently extracted and assessed study data using standardised forms. Additional unpublished data were obtained from trial authors. The primary endpoint 'any cardiac event' was a composite of cardiac death, non-fatal myocardial infarction (MI), unstable angina (UA), or heart failure (HF) hospitalisation. We performed a meta-analysis of relative risks (RRs) with 95% confidence intervals (CI) using the Mantel-Haenszel method. We included five RCT's with 3299 patients, of which 189 (5.7%) experienced any cardiac event on follow-up (weighted mean 4.1 years). Non-invasive CAD screening significantly reduced any cardiac event by 27% [RR 0.73 (95% CI 0.55-0.97), P = 0.028, number needed to screen 56]. This result was driven by important, albeit non-significant decreases in non-fatal MI [RR 0.65 (95% CI 0.41-1.02), P = 0.062] and HF hospitalisation [RR 0.61 (95% CI 0.33-1.10), P = 0.100]. Non-invasive CAD screening did not significantly affect cardiac death [RR 0.92 (95% CI 0.53-1.60), P = 0.77] and UA [RR 0.73 (95% CI 0.41-1.31), P = 0.29]. Compared with the standard care, non-invasive CAD screening reduced cardiac events by 27% in asymptomatic diabetic patients, largely through reductions in non-fatal MIs, and HF hospitalisations. The present results justify larger, appropriately powered trials to potentially revisit current recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763 · cited 1×
“The current standards of care for asymptomatic diabetic patients are based on risk factor modification, lifestyle changes, and medical therapy.(6,10) However, the high cardiovascular risk in these patients has also generated substantial interest in the early detection of silent CAD by screening tests.”
BackgroundOptimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699 · cited 4×
“However, with the exception of EET, all CAD imaging tests have demonstrated uniformly a very high sensitivity and specificity for detecting CAD.40 Moreover, all non-invasive tests predict cardiac events based on the severity of their findings, also in patients with diabetes.8,11,14,15 Furthermore, the extent of diseas…”
BackgroundInfluentialA modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267 · cited 1×
“Publication bias was evaluated using funnel plots(26) and the Harbord–Egger test for asymmetry.(27,28) Finally, overall quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method(29) updated by the Evidence-based Practice Centre.”
MethodA Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805796 · Cited by 1,939 · cited 4×
“However, with the exception of EET, all CAD imaging tests have demonstrated uniformly a very high sensitivity and specificity for detecting CAD.40 Moreover, all non-invasive tests predict cardiac events based on the severity of their findings, also in patients with diabetes.8,11,14,15 Furthermore, the extent of diseas…”
BackgroundInfluentialStatins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Young, L. H., Wackers, F. J. T., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Heller, G. V., Iskandrian, A. E., Wittlin, S. D., Filipchuk, N., et al. (2009) · JAMA · doi:10.1001/jama.2009.476 · Cited by 809 · cited 5×
“Thus, presumably those patients with the largest expected benefit from revascularization were withheld.12 These discrepancies between individual and recommended treatment decisions may account to some extent for the lack of benefit in the screening arm of DIAD.22 In DYNAMIT and DADDY-D, drug usage and revascularizatio…”
BackgroundMethodInfluentialMuhlestein, J. B., Lappé, D. L., Lima, J. A. C., Rosen, B. D., May, H. T., Knight, S., Bluemke, D. A., Towner, S. R., Le, V., Bair, T. L., et al. (2014) · JAMA · doi:10.1001/jama.2014.15825 · Cited by 373 · cited 5×
“However, these trials may have suffered from under-sampling and potential statistical Type II error due to lower event rates than anticipated.(22,23) We, therefore, sought to perform a systematic review and metaanalysis of published RCT’s to assess more precisely and with higher statistical power the potential reducti…”
BackgroundResultInfluential8. Cardiovascular Disease and Risk Management
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s011 · Cited by 329
Grading the strength of a body of evidence when assessing health care interventions: an EPC update
Berkman, N. D., Lohr, K. N., Ansari, M. T., Balk, E. M., Kane, R., McDonagh, M., Morton, S. C., Viswanathan, M., Bass, E. B., Butler, M., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.11.023 · Cited by 279 · cited 2×
“The risk of study bias was assessed at the study and outcome level using the Cochrane Collaboration’s tool.25 Publication bias was evaluated using funnel plots26 and the Harbord–Egger test for asymmetry.27,28 Finally, overall quality of evidence was assessed using the Grading of Recommendations Assessment, Development…”
Method
Cited by
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Metadata
- Authors
- Clerc, O. F., Fuchs, T. A., Stehli, J., Benz, D. C., Gräni, C., Messerli, M., Giannopoulos, A. A., Buechel, R. R., Lüscher, T. F., Pazhenkottil, A. P., Kaufmann, P. A., & Gaemperli, O.
- Venue
- European Heart Journal - Cardiovascular Imaging
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-14
- Volume
- 19
- Issue
- 8
- Pages
- 838-846
- ISSN
- 2047-2404 (ISSN-L)
- 2047-2412
- OpenAlex
- W2790347086
- Cited by
- 56
- References
- 10
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. https://app.cochat.ai/papers/10.1093/ehjci/jey014
- The paper
- Clerc, O. F., Fuchs, T. A., Stehli, J., Benz, D. C., Gräni, C., Messerli, M., Giannopoulos, A. A., Buechel, R. R., Lüscher, T. F., Pazhenkottil, A. P., Kaufmann, P. A., & Gaemperli, O. (2018). Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jey014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.